Diabetic foot complication risk highlighted in men

NewsGuard 100/100 Score

By Lynda Williams, Senior medwireNews Reporter

Men should be considered for aggressive treatment for foot complications associated with diabetes, such as ulceration and amputation, say researchers.

The study, published in Endocrine, indicates that male gender may be a significant predictor for diabetic foot outcomes, alongside the well-characterized risk factors for diabetic neuropathy and peripheral vascular disease.

"This difference in gender is attributable to better wound care in women, as men are more commonly involved in heavy physical work activities and deal with more social pressure to keep providing the family income," suggest Maria Candida Ribeiro Parisi (University of Campinias, Brazil) and co-workers.

"Also important, absenteeism is higher among men. These issues cause ulcerations to take longer to recover, being more likely to present at a consult at any given moment, and also more likely to terminate in amputation," they emphasize.

The team reviewed medical records for 496 patients with a diagnosis or risk factors for diabetic foot. The majority of patients had Type 2 diabetes (94%), 48.6% of patients were male, and the average diabetes duration was 16.8 years. Most of the patients were treated with insulin (80.8%), and 67.3% also received oral drugs.

At the last foot clinic visit, 45.9% of patients had diabetic foot deformity, 25.3% had foot ulceration, and 12.9% had undergone amputation. Two-thirds (67.2%) of patients had no present or past history of ulceration or amputation.

Of note, 92.9% of the patients had diabetic neuropathy, 30% had neuro-ischemic disease, and 7.1% had only ischemic disease. Neuropathy with no evidence of arteriopathy was reported in 62% of patients.

Patients with neuro-ischemic symptoms or neuropathy alone were significantly more likely than patients with only ischemic symptoms to have foot deformity (46 and 48 vs 22%), regardless of age, gender, and diabetes duration or type.

Ulceration was significantly more common in men than women (33.0 vs 18.0%), and male gender was the only significant risk factor for ulceration in multivariate analysis (odds ratio [OR]=2.15).

Amputation was also significantly more common in men than women (20 vs 7%), and in patients with neuro-ischemic disease than neuropathy or ischemic disease alone (21 vs 9 and 6%, respectively), with multivariate analysis ORs of 3.44 and 4.6, respectively, for these risk factors.

"We thus believe that older men, presenting combined risk factors should be a group receiving more special attention and aggressive treatment in the foot clinic, due to their potentially worse evolution," Parisi et al conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

  1. frank frank United Kingdom says:

    get your diabetes under control... this is the real issue
    for me. I was able to improve my neuropathy with diabetes uncut.

  2. lousie lousie United States says:

    I am a girl but this is worrying, these statistics are frightening. Diabetes is the worst disease ever with all of these complications.
    I too have heard that diabetes uncut is helping people with
    neuropathy i must look into getting it.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint